Andrew Talal, University at Buffalo (IMAGE)

University at Buffalo

Andrew Talal, University at Buffalo

Caption

Talal led the study, which is the first to track in real-time, how the drug telaprevir inhibits viral replication in the liver.

Credit

Douglas Levere, University at Buffalo

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.